))
‘It’s pretty gobsmacking, isn’t it’
Manage episode 429219014 series 2818133
Content provided by Australian Journal of Pharmacy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Journal of Pharmacy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Chief pharmacist with the Capital Chemist Group Andrew Topp talks about the lack of consultation surrounding 60-day consulting, and questions the competence of decision-makers
Speaking to Carlene McMaugh for the AJP Podcast, Topp said that the senior staff who run the Health Department, “Quite frankly…do not understand this at all”.
“It’s pretty gobsmacking, isn’t it, that this can be dreamed up as a concept – obviously, a long time ago, without us being aware of it – and then landed in pharmacy’s lap with literally a few weeks to work out how they’re going to handle the impacts,” Topp tells McMaugh in this discussion on double dispensing.
This goes “right down to the granular level,” he said, questioning how patients will access methadone, how extra services will be managed with fewer staff, how aged care changes will take place and how pharmacies can build infrastructure without a sufficient income stream.
Topp calls the impact analysis used to support the measure “embarrassing” and “was written to retrofit the policies”.
“We know there will be pharmacies that do not survive this.”
Go here for the full list of active AJP podcasts. These can also be accessed via Google Podcasts, Apple Podcasts and Spotify
98 episodes
Share
